Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

While both are called medullary carcinoma, these cancers differ in many ways: ...

Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

Breanna Bortner, from Minnesota, was previously diagnosed with stage 2B triple-negative invasive ductal carcinoma - a type of ...

Medically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

Oncorena is pleased to announce that the FDA has approved the Company's IND application to initiate the Phase I/II study Oncorella-1: A Phase 1/2 ...